McAdam LLC
MRNA icon

McAdam LLC’s Moderna MRNA Stock Holding History

McAdam LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$212K Buy
+1,099
New +$118K 0.01% 480
2025
Q1 		– Sell
-11,768
Closed -$489K – 373
2024
Q4 		$489K Buy
11,768
+562
+5% +$26.9K 0.03% 207
2024
Q3 		$749K Buy
11,206
+131
+1% +$12K 0.04% 155
2024
Q2 		$1.32M Buy
11,075
+117
+1% +$14.8K 0.08% 103
2024
Q1 		$1.17M Sell
10,958
-39
-0.4% -$3.93K 0.07% 107
2023
Q4 		$1.09M Buy
10,997
+2,529
+30% +$213K 0.08% 102
2023
Q3 		$875K Buy
8,468
+562
+7% +$62.7K 0.07% 117
2023
Q2 		$961K Buy
7,906
+1,092
+16% +$146K 0.08% 112
2023
Q1 		$1.05M Buy
6,814
+3,094
+83% +$510K 0.09% 108
2022
Q4 		$945K Sell
3,720
-1,399
-27% -$229K 0.09% 79
2022
Q3 		$605K Buy
5,119
+754
+17% +$114K 0.07% 120
2022
Q2 		$624K Buy
4,365
+159
+4% +$22.7K 0.07% 122
2022
Q1 		$725K Buy
4,206
+486
+13% +$81.8K 0.07% 94
2021
Q4 		$945K Buy
3,720
+1,336
+56% +$391K 0.09% 79
2021
Q3 		$918K Sell
2,384
-22
-0.9% -$8.11K 0.1% 76
2021
Q2 		$832K Buy
2,406
+106
+5% +$18.9K 0.09% 76
2021
Q1 		$301K Buy
+2,300
New +$333K 0.04% 120

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures, LLc
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

McAdam LLC's MRNA Position: Q3 2026 in Review

McAdam LLC opened a new position in Moderna (MRNA) in Q3 2026: 1,099 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #480 among its holdings. This is a return to the name: McAdam LLC previously reported a position in MRNA as recently as Q4 2024.

McAdam LLC first reported a position in MRNA in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.32M in Q2 2024. 242 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • McAdam LLC held 1,099 shares of Moderna worth $212K as of Q3 2026.
  • Moderna was a new McAdam LLC position in Q3 2026.
  • Moderna made up 0.01% of McAdam LLC's portfolio in Q3 2026, its #480 holding.
  • McAdam LLC first reported a position in Moderna in Q1 2021 and has held it in 17 quarters since.
  • McAdam LLC's Moderna position peaked at $1.32M in Q2 2024.
  • 242 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on McAdam LLC's 13F filing for Q3 2026, filed 21 Oct 2026.